Acelyrin

Last updated: July 09, 2024

CEO Shao-Lee Lin
CEO Shao-Lee Lin
USA | Funding: $558M (+)

Website: https://acelyrin.com/

ACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing inflammatory-disease-focused therapies.